AU2019401254B2 - Analogs that target mitochondrial diseases - Google Patents
Analogs that target mitochondrial diseases Download PDFInfo
- Publication number
- AU2019401254B2 AU2019401254B2 AU2019401254A AU2019401254A AU2019401254B2 AU 2019401254 B2 AU2019401254 B2 AU 2019401254B2 AU 2019401254 A AU2019401254 A AU 2019401254A AU 2019401254 A AU2019401254 A AU 2019401254A AU 2019401254 B2 AU2019401254 B2 AU 2019401254B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- nynh
- ischemia
- group
- aaa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862781156P | 2018-12-18 | 2018-12-18 | |
| US62/781,156 | 2018-12-18 | ||
| PCT/US2019/062284 WO2020131283A1 (en) | 2018-12-18 | 2019-11-19 | Analogs that target mitochondrial diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019401254A1 AU2019401254A1 (en) | 2021-06-24 |
| AU2019401254B2 true AU2019401254B2 (en) | 2025-05-01 |
Family
ID=71101584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019401254A Active AU2019401254B2 (en) | 2018-12-18 | 2019-11-19 | Analogs that target mitochondrial diseases |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12252554B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3898653A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7606966B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102995415B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113383005A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019401254B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3123610A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL284014A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020131283A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113544138B (zh) | 2018-12-18 | 2024-10-29 | 隐形生物治疗公司 | 线粒体靶向肽 |
| WO2020131283A1 (en) | 2018-12-18 | 2020-06-25 | Stealth Biotherapeutics Corp. | Analogs that target mitochondrial diseases |
| US20240197623A1 (en) * | 2021-04-07 | 2024-06-20 | Stealth Bio Therapeutics Inc. | Silica-based formulations of therapeutic oliogpeptides and peptidomimetics |
| KR102876070B1 (ko) * | 2023-02-08 | 2025-10-24 | 웰펩 주식회사 | 신규 펩티도미메틱을 유효성분으로 포함하는 아토피 피부염의 예방 또는 치료용 조성물 |
| WO2026151834A1 (en) | 2025-01-09 | 2026-07-16 | Stealth Biotherapeutics Inc. | Compounds for use in medical management of subjects with muscular dystrophy |
| WO2026151846A1 (en) | 2025-01-09 | 2026-07-16 | Stealth Biotherapeutics Inc. | Compositions for use in the treatment of heart failure, idiopathic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, hypertrophic cardiomyopathy, or hypertensive cardiomyopathy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011091357A1 (en) * | 2010-01-25 | 2011-07-28 | Cornell University | Aromatic-cationic peptides and uses of same |
| WO2017117381A1 (en) * | 2015-12-31 | 2017-07-06 | Scott Duncan | Therapeutic compositions including peptides and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2656854T1 (sl) | 2003-02-04 | 2015-09-30 | Cornell Research Foundation, Inc. | Uporabe aromatsko-kationskega peptida |
| EP2808029A3 (en) | 2010-03-15 | 2015-04-01 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
| CN103249423A (zh) | 2010-07-09 | 2013-08-14 | 康肽德生物医药技术有限公司 | 预防或治疗缺血/再灌注损伤之后无复流的方法 |
| US8383919B2 (en) | 2010-12-14 | 2013-02-26 | Xueyun Gao | Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| EP3108975A1 (en) | 2011-03-24 | 2016-12-28 | Cornell University | Aromatic-cationic peptides and uses of same |
| CA2865409C (en) | 2012-02-23 | 2020-07-21 | Cornell University | Aromatic-cationic peptides and uses of same |
| EP3626252A1 (en) | 2013-03-01 | 2020-03-25 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention or treatment of barth syndrome |
| CA2916492A1 (en) | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
| CN106459169A (zh) | 2014-03-03 | 2017-02-22 | 康德生物医疗技术公司 | 药学上相关的芳香族阳离子肽 |
| WO2015183984A2 (en) | 2014-05-28 | 2015-12-03 | Stealth Peptides International, Inc. | Therapeutic compositions including tocopherol and uses thereof |
| WO2016144352A2 (en) | 2015-03-11 | 2016-09-15 | Stealth Peptides International, Inc. | Therapeutic compositions including acrylamido compounds or phenyl-substituted maleimide compounds, variants thereof and methods of using the same |
| WO2017093897A1 (en) | 2015-11-30 | 2017-06-08 | Peter Schiller | Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome |
| US10870678B2 (en) | 2016-04-11 | 2020-12-22 | Arcuate Therapeutics, Inc. | Chiral peptides |
| US20190276494A1 (en) | 2016-05-19 | 2019-09-12 | Stealth Biotherapeutics Corp. | Compositions and methods for the prevention and treatment of mitochondrial myopathies |
| WO2018186404A1 (ja) * | 2017-04-03 | 2018-10-11 | 出光興産株式会社 | 有機エレクトロルミネッセンス素子及び電子機器 |
| WO2018223032A1 (en) | 2017-06-02 | 2018-12-06 | Stealth Biotherapeutics Corp. | Crystalline salt forms of sbt-20 |
| US20200361987A1 (en) | 2017-11-15 | 2020-11-19 | Stealth Biotherapeutics Corp. | Deuterated tetrapeptides that target mitochondria |
| CN113544138B (zh) | 2018-12-18 | 2024-10-29 | 隐形生物治疗公司 | 线粒体靶向肽 |
| WO2020131283A1 (en) | 2018-12-18 | 2020-06-25 | Stealth Biotherapeutics Corp. | Analogs that target mitochondrial diseases |
-
2019
- 2019-11-19 WO PCT/US2019/062284 patent/WO2020131283A1/en not_active Ceased
- 2019-11-19 JP JP2021533856A patent/JP7606966B2/ja active Active
- 2019-11-19 US US17/414,168 patent/US12252554B2/en active Active
- 2019-11-19 KR KR1020217018416A patent/KR102995415B1/ko active Active
- 2019-11-19 CA CA3123610A patent/CA3123610A1/en active Pending
- 2019-11-19 CN CN201980083870.0A patent/CN113383005A/zh active Pending
- 2019-11-19 EP EP19900766.7A patent/EP3898653A4/en active Pending
- 2019-11-19 AU AU2019401254A patent/AU2019401254B2/en active Active
-
2021
- 2021-06-15 IL IL284014A patent/IL284014A/en unknown
-
2025
- 2025-02-10 US US19/049,634 patent/US20260008810A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011091357A1 (en) * | 2010-01-25 | 2011-07-28 | Cornell University | Aromatic-cationic peptides and uses of same |
| WO2017117381A1 (en) * | 2015-12-31 | 2017-07-06 | Scott Duncan | Therapeutic compositions including peptides and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| CERRATO C. P., et al., 2015, "Novel cell‐penetrating peptide targeting mitochondria", FASEB Journal, 29(11), pages 4589-4599 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113383005A (zh) | 2021-09-10 |
| AU2019401254A1 (en) | 2021-06-24 |
| WO2020131283A1 (en) | 2020-06-25 |
| EP3898653A1 (en) | 2021-10-27 |
| KR20210093958A (ko) | 2021-07-28 |
| US20220041654A1 (en) | 2022-02-10 |
| KR102995415B1 (ko) | 2026-07-23 |
| CA3123610A1 (en) | 2020-06-25 |
| US20260008810A1 (en) | 2026-01-08 |
| US12252554B2 (en) | 2025-03-18 |
| JP7606966B2 (ja) | 2024-12-26 |
| EP3898653A4 (en) | 2022-08-24 |
| JP2022514241A (ja) | 2022-02-10 |
| IL284014A (en) | 2021-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260008810A1 (en) | Analogs that target mitochondrial diseases | |
| CN103191410B (zh) | T-细胞介导的疾病的治疗 | |
| JP3405460B2 (ja) | ヘプタペプチドオキシトシン類似体 | |
| US20240092832A1 (en) | Deuterated tetrapeptides that target mitochondria | |
| RU2151776C1 (ru) | Циклопептиды, способ их получения | |
| JP2003524001A (ja) | 新規マロン酸誘導体、それらの製造法、第Xa因子活性の抑制剤としてのそれらの使用、およびそれらを含有する医薬組成物 | |
| US20260055136A1 (en) | Mitochondria-targeting peptides | |
| EP0701567A1 (en) | New peptides derivatives | |
| JPH09511500A (ja) | N−置換化グリシンを含むブラジキニン拮抗薬ペプチド | |
| JP4563806B2 (ja) | P−セレクチンに対する結合性化合物 | |
| WO2021262710A1 (en) | Prodrugs of mitochodria-targeting oligopeptides | |
| US20230227499A1 (en) | Prodrugs of mitochondria-targeting oligopeptides | |
| CA1154757A (en) | Synthetic peptides | |
| JPH08183740A (ja) | 細胞接着阻害剤及び該阻害剤を含む抗炎症剤 | |
| JPH083190A (ja) | 細胞接着活性コア配列の繰り返し構造からなるポリペプチド | |
| HRP930498A2 (en) | Glycine derivatives | |
| CN101168560A (zh) | N-取代肽酰胺,其药物组合物与用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: STEALTH BIOTHERAPEUTICS INC. Free format text: FORMER APPLICANT(S): STEALTH BIOTHERAPEUTICS CORP. |
|
| FGA | Letters patent sealed or granted (standard patent) |